BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8367814)

  • 1. Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration.
    Curley SA; Byrd DR; Newman RA; Ellis HJ; Chase J; Carrasco CH; Cleary K; Bodden W; Hohn DC
    Surgery; 1993 Sep; 114(3):579-85. PubMed ID: 8367814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study.
    Curley SA; Newman RA; Dougherty TB; Fuhrman GM; Stone DL; Mikolajek JA; Guercio S; Guercio A; Carrasco CH; Kuo MT
    Ann Surg Oncol; 1994 Sep; 1(5):389-99. PubMed ID: 7850540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: a feasibility study of a novel system.
    Curley SA; Byrd DR; Newman RA; Carrasco CH; Cromeens D; Ellis HJ; Chase J; Dougherty T; Wright K; Bodden W
    Anticancer Drugs; 1991 Apr; 2(2):175-83. PubMed ID: 1958862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic artery infusion of doxorubicin with hepatic venous drug extraction.
    August DA; Verma N; Andrews JC; Vaerten MA; Brenner DE
    J Surg Res; 1994 Jun; 56(6):611-9. PubMed ID: 8015319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration.
    Curley SA; Stone DL; Fuhrman GM; Hohn DC; Siddik ZH; Newman RA
    Cancer Chemother Pharmacol; 1993; 33(3):251-7. PubMed ID: 8269607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic arterial infusion of verapamil and doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration: pharmacological evaluation of reduction in systemic drug exposure and assessment of hepatic toxicity.
    Fuhrman GM; Cromeens DM; Newman RA; Cleary KR; Carrasco CH; Wright KC; Guercio S; Guercio A; Curley SA
    Surg Oncol; 1994 Feb; 3(1):17-25. PubMed ID: 8186867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
    Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
    Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors.
    Ravikumar TS; Pizzorno G; Bodden W; Marsh J; Strair R; Pollack J; Hendler R; Hanna J; D'Andrea E
    J Clin Oncol; 1994 Dec; 12(12):2723-36. PubMed ID: 7989950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors.
    Ku Y; Fukumoto T; Tominaga M; Iwasaki T; Maeda I; Kusunoki N; Obara H; Sako M; Suzuki Y; Kuroda Y; Saitoh Y
    Am J Surg; 1997 Feb; 173(2):103-9. PubMed ID: 9074373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of hepatic doxorubicin extraction with extracorporeal filtration avoids the dose-dependent, nonlinear increase in AUC observed with systemic administration.
    Sturgill MG; Brenner DE; August DA
    Cancer Chemother Pharmacol; 1998; 41(3):193-200. PubMed ID: 9443635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe anesthetic management of patients undergoing a novel method of treating human hepatocellular cancer.
    Dougherty TB; Mikolajek JA; Curley SA
    J Clin Anesth; 1997 May; 9(3):220-7. PubMed ID: 9172030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic evaluation of percutaneous hepatic venous isolation for administration of regional chemotherapy.
    August DA; Verma N; Vaerten MA; Shah R; Andrews JC; Brenner DE
    Surg Oncol; 1995 Aug; 4(4):205-16. PubMed ID: 8528483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracorporeal adriamycin-removal following hepatic artery infusion: use of direct hemoperfusion combined with veno-venous bypass].
    Ku Y; Saitoh M; Nishiyama H; Fujiwara S; Iwasaki T; Ohyanagi H; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1758-64. PubMed ID: 2594003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic clearance of endotoxins: differences in arterial and portal venous infusion.
    Wolter J; Liehr H; GrĂ¼n M
    J Reticuloendothel Soc; 1978 Feb; 23(2):145-52. PubMed ID: 627996
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic comparison of intraarterial and intraportal infusion of adriamycin in regional chemotherapy of the liver].
    Shiotani M; Ku Y; Kusunoki N; Kitagawa T; Maeda I; Tominaga M; Tanigawara Y; Kuroda Y; Saitoh Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1560-2. PubMed ID: 7574759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic evaluation of complete infrarenal inferior vena caval isolation and charcoal hemoperfusion for intra-arterial chemotherapy of pelvic tumors].
    Maeda I; Ku Y; Tominaga M; Iwasaki T; Kitagawa T; Shiotani M; Kuroda Y; Saitoh Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1563-5. PubMed ID: 7574760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of hepatic extraction and clearance of doxorubicin.
    August DA; Verma N; Vaertan MA; Shah R; Brenner DE
    Br J Cancer; 1995 Jul; 72(1):65-71. PubMed ID: 7599068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
    Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH
    Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy.
    Graham RA; Siddik ZH; Hohn DC
    Cancer Chemother Pharmacol; 1990; 26(3):210-4. PubMed ID: 2357769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model.
    Yee C; McCoy D; Yu J; Losey A; Jordan C; Moore T; Stillson C; Oh HJ; Kilbride B; Roy S; Patel A; Wilson MW; Hetts SW;
    Radiol Imaging Cancer; 2019 Sep; 1(1):e190009. PubMed ID: 32300759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.